Two Sigma Securities’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-263,323
Closed -$31.6K 2395
2024
Q4
$31.6K Buy
+263,323
New +$33.2K ﹤0.01% 1241
2024
Q3
Sell
-254,663
Closed -$37.2K 3854
2024
Q2
$37.2K Buy
254,663
+215,158
+545% +$32.2K ﹤0.01% 2610
2024
Q1
$5.76K Sell
39,505
-381,447
-91% -$53.4K ﹤0.01% 2821
2023
Q4
$84.3K Buy
+420,952
New +$74K ﹤0.01% 2539
2023
Q3
Sell
-371,870
Closed -$74.4K 3673
2023
Q2
$74.4K Buy
371,870
+326,467
+719% +$66.2K ﹤0.01% 2348
2023
Q1
$9.61K Sell
45,403
-83,497
-65% -$20.5K ﹤0.01% 2460
2022
Q4
$21K Buy
128,900
+5,397
+4% +$1.11K ﹤0.01% 2269
2022
Q3
$26K Buy
123,503
+96,429
+356% +$25.5K ﹤0.01% 2270
2022
Q2
$6K Sell
27,074
-82,267
-75% -$20.9K ﹤0.01% 2108
2022
Q1
$37K Sell
109,341
-37,443
-26% -$12.3K ﹤0.01% 1910
2021
Q4
$45K Buy
146,784
+45,828
+45% +$20.6K ﹤0.01% 1291
2021
Q3
$53K Buy
+100,956
New +$59.6K ﹤0.01% 1380
2021
Q2
Sell
-15,291
Closed -$24K 1811
2021
Q1
$24K Buy
+15,291
New +$25K ﹤0.01% 771
2020
Q4
Sell
-65,821
Closed -$7K 2075
2020
Q3
$7K Buy
+65,821
New +$9.07K ﹤0.01% 1258
2018
Q3
Sell
-13,298
Closed -$30K 3171
2018
Q2
$30K Buy
+13,298
New +$26.7K ﹤0.01% 2542

Other funds holding ZOM

Two Sigma Securities's ZOM Position: Q1 2025 in Review

Two Sigma Securities sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 263,323 shares — an estimated $31.6K sold.

Two Sigma Securities first reported a position in ZOM in Q2 2018 and held it in 15 quarters. The position peaked at $84.3K in Q4 2023. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Two Sigma Securities reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 263,323 Zomedica Corp. shares in Q1 2025, an estimated $31.6K.
  • Two Sigma Securities first reported a position in Zomedica Corp. in Q2 2018 and held it in 15 quarters.
  • Two Sigma Securities's Zomedica Corp. position peaked at $84.3K in Q4 2023.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.